Lawrence Hamel - Chief Development Officer, Acelrx Pharmaceuticals Inc

As of February 13, 2020


Lawrence Hamel Net Worth

  • Net worth is estimated to be at least $256.51K
  • Owns at least 107,848 units of Acelrx Pharmaceuticals Inc stock
  • Sold an estimated value of $294.91K in the last 9 years at Acelrx Pharmaceuticals Inc

Lawrence Hamel Trading

  • Largest purchase of shares was 3,682 units , worth over $10.35K on March 4, 2019
  • Largest sale of shares was 10,161 units , worth over $53.75K on October 3, 2017
  • In total has made about 36 transactions over 9 years
  • Usually trades in February, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Lawrence Hamel Mailing Address

  • Mailing address is C/o Acelrx Pharmaceuticals Inc. 351 Galveston Drive Redwood City CA 94063 CA

Acelrx Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 100,000 units sold on June 15, 2020 by Adrian Adams worth over $128.9K
  • In the last 9 years, insiders at Acelrx Pharmaceuticals Inc sold an estimated value of $23.76M and bought an estimated value of $52.85M
  • The most active traders are Lawrence Hamel, Chief Development Officer,  Mark Edwards, Director,  and Badri Dasu, Chief Engineering Officer
  • Insider trading is most common in February, with the busiest year in 2018

ACELRX PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1